All Classification Tables are Important .
(MINI KATZUNG )
ANS :
·
Chap 6 : Cholinergic/Adrenergic Transmission
,Cholinoceptors.
·
Chap 7 : Tissue and Organ Effects, Table 7-3
·
Chap 8: Pharmacokinetics of Muscuranic
Antagonists, It’s Effects, Contraindications, Cholinesterase Regenerators,
Trimethaphan
·
Chap 9: M.O.A, Effects on CNS , Eye, Vascular
System and Heart ,Table 9-1, Clinical Uses in CVS ,bronchi and genitourinary
tract.
CVS :
·
Chap 11: Table 11-1,Sympathoplegics, fig 11-1,
Angiotensin antagonists and rennin inhibitor,fig 11-3.
·
Chap12 : fig12-1, Nitrates, effects of Calcium
channel blocking drugs, table 12-1, newer drugs.
·
Chap 13 : fig 13-1,2, Cardiac effects of cardiac
glycosides, digitalis toxicity, phosphodiesterase inhibitors.
·
Chap 14 : Torsades de pointes,table 14-1,group 3
antiarrhythmics,fig 14-4,6.
Diuretics :
·
Chap 15 : Whole.
Autacoids :
·
Chap 16 : table 16-1,Hitamine receptors and
effects, serotonin clinical uses, hyperpyrexic syndromes, ergots alkaloids
·
Prostaglandins (chap 18 ) : synthesis,M.O.A, fig
18-1.Clinical Uses.
Respo:
·
Chap 20 : whole
GIT :
·
Chap 59 : PPI, Colloidal bismuth, Drugs
promoting GIT motility, Drugs for IBS, Drugs for IBD, Antidiarrheal drugs.
CNS:
·
Chap 21 : fig 21-1, table21-1.
·
Chap 22: Benzodiazepines, Barbiturates,
Pharmacodynamics, Toxicity, Buspirone, Ramelton side effects.
·
Chap 23 : Acute and chronic effects of ethanol,
tolerance
·
Chap 24 : phenytoin,carbamazepine,
M.O.A,toxicity , benzodiazepines + lamotrigine+phenytoin+valproic acid from
table 24-1
·
Chap 25: Stages of Anasthesia ,fig 25-1, minimum
alveolar anesthetic conc, effects of inhaled anesthetics ,ketamine,etomidate.
·
Chap 26: Route of Administration,
M.O.A,fig26-1,toxicity.
·
Chap 28: levadopa, MAOI,amantadine.
·
Chap 29:M.O.A, toxicity,Lithium
·
Chap 30: TCAs, SSRIs, SNRIs.clinical uses,
toxicity of TCAs and SSRI, serotonin syndrome.
·
Chap 31 : M.O.A of morphine,acute effects,
clinical uses,management of acute pulmonary edema,toxicity,naloxone.
BLOOD:
·
Chap 33: IRON
·
Chap 34 : heparin,table34-1,warfarin,aspirin.
·
Chap 35: drugs treatment strategies,familial
hypertriglyceridemia, niacin
·
Chap 36: asprin uses,
moa,toxicity,interactions,Acetaminophen toxicity, DMARDs,leflunomide,allopurinol
ENDOCRINE :
·
Chap 37 :fig37-1,
mecasermine,prolactin,Endogenous gonadotropin Production.
·
Chap 38 : synthesis and transport of thyroid
hormones,M.O.A, fig 38-1,table38-1,effects of TH,antithyroid drugs-thioamide
·
Chap 39: M.O.A, organ and tissue effect,fig
39-1,clinical uses,synthesis inhibitors.
·
Chap 40: hormonal contraceptives,fig
40-1,2,clomiphene.
·
Chap 41:Insulin effects,preparation, Noninsulin
antidiabetic drugs-Insulin secretagogues,alpha-glucoside inhibitors,exenatide,Type
1&2 Diabetes.
·
Chap 42 : bisphosphonates